Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Bone Morphogenetic Proteins Market Outlook

The global bone morphogenetic proteins market is expected to grow at a CAGR of 2.3% during the period 2024-2032. North America, Europe and Asia are likely to be key markets.

bone morphogenetic proteins market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Market Likely to be Driven by Uses in a Variety of Processes During the Formation and Maintenance of Organs such as Bone, Cartilage, and Muscle, Among Others

Bone morphogenetic proteins (BMPs) is the common name of a family of proteins, recognized first in extracts of demineralized bone that were capable of encouraging bone formation at ectopic sites. Bone morphogenetic proteins are present in small amounts in bone material (nearly 1 microgram/kg dry weight of bone). Generally, the term bone morphogenetic proteins describes a certain function of these proteins, which have been implicated also in many other processes. Bone morphogenetic proteins such as BMP2, BMP4, and BMP7 also play a role in the specification of hematopoietic tissue from the mesodermal germ layer.

Bone morphogenetic proteins belong to the family of transforming growth factors. Presently, nearly twenty different bone morphogenetic proteins have been identified, all with different degrees of tissue stimulating properties. Bone morphogenetic proteins play important roles in a broad range of processes during the formation and maintenance of organs such as bone, cartilage, muscle, kidney, and blood vessels. As deregulation of the bone morphogenetic protein activity at multiple steps in signal transduction is associated with several human diseases, therapeutic use of activators and inhibitors of bone morphogenetic proteins signaling would provide potential avenues for the treatment of human ailments caused by hypo- and hyperactivation of bone morphogenetic proteins signals.

Applications of Bone Morphogenetic Proteins in Domains Such as Dentistry, Orthopaedics, Sports Likely to Boost Market Growth

Bone tissue is a mineralized structure with complex metabolism, and given its mechanical functions, its structure must be adapted to bone function. Bone morphogenetic proteins group stimulates the formation of bone and cartilage and influences several non-osteogenic processes. Due to their osteogenic effect, bone morphogenetic proteins are employed in several areas of medicine, including dentistry, orthopaedics, sport and rehabilitation. Such applications are expected to drive the global bone morphogenetic proteins market. Recombinant human bone morphogenetic proteins (rhBMPs) are administered to the bone grafting site through surgery. Bone morphogenetic proteins stimulate bone growth naturally in the human body. These proteins that exist in the body can be produced, concentrated and placed in the area of the spine for spinal fusion to occur.  More importantly, these can generate fusion without the need for any use of the patient’s own bone.

Bone morphogenetic protein 2 (BMP-2) is a member of the BMP subgroup of the TGFβ superfamily. It plays an important role in embryonic dorsalventral patterning, organogenesis, limb bud formation, and bone formation and regeneration. Bone morphogenetic protein 2 is an effective osteoinductive cytokine, capable of inducing bone and cartilage formation in association with osteoconductive carriers such as collagen and synthetic hydroxyapatite. Bone morphogenetic protein 2 also plays a key role in cardiac morphogenesis and is expressed in multiple tissues including lung, spleen, brain, liver, prostate ovary and small intestine.

Advanced Solutions Likely to Stimulate Market Growth

InfuseTM Bone Graft is a premium product for autograft replacement due to its high osteoinductivity. Infuse bone graft is recombinant human bone morphogenetic protein-2 (rhBMP-2) applied to an absorbable collagen sponge carrier (ACS). One of the functions of the protein is to inspire natural bone formation. INFUSE® Bone Graft is a revolutionary bone graft that helps inspire natural bone formation and remodelling and circumvents the need to harvest bone from other parts of a patient’s body. Infuse has been on the market since 2002 and used in over 1 million patients across the world. Such solutions are expected to drive growth of the global bone morphogenetic proteins market. Infuse is indicated for certain spinal fusion procedures in skeletally mature patients with degenerative disc disease (DDD) from L2 to S1, as well as for treating certain acute, open tibial shaft fractures. Infuse is also approved for certain oral-maxillofacial procedures.

Market Segmentation

bone morphogenetic proteins market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By type, the market is segmented into:

  • Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2
  • Recombinant Human Bone Morphogenetic Protein (rhBMP) -7

By application, the market is divided into:

  • Spinal Fusion
  • Trauma 
  • Reconstructive Surgery
  • Oral-maxillofacial

By region, the market is classified into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

bone morphogenetic proteins market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Industry Players in the Market

The report presents a detailed analysis of the following key players in the global bone morphogenetic proteins market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Thermo Fisher Scientific, Inc.
  • Medtronic plc
  • Prospec-Tany Technogene Ltd.
  • Merck KGaA
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Application
  • Region
Breakup by Type
  • Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2
  • Recombinant Human Bone Morphogenetic Protein (rhBMP) -7
Breakup by Application
  • Spinal Fusion
  • Trauma
  • Reconstructive Surgery
  • Oral-maxillofacial
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Thermo Fisher Scientific, Inc.
  • Medtronic plc
  • Prospec-Tany Technogene Ltd.
  • Merck KGaA
  • Others

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The global bone morphogenetic proteins market is projected to grow at a CAGR of 2.3% between 2024 and 2032.

The major drivers of the market include the rising geriatric population, established healthcare infrastructure, high adoption of advanced technology by orthopaedic surgeons, favourable reimbursement structure, increasing awareness among surgeons for using rhBMPs, increasing healthcare spending capacity, and growing medical tourism in countries.

Increasing number of people suffering from spinal injuries and an increase in surgical rate are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Based on type, the market is classified into recombinant human bone morphogenetic protein (rhBMP) – 2 and recombinant human bone morphogenetic protein (rhBMP) -7.

The major applications of the market are spinal fusion, trauma, reconstructive surgery, and oral-maxillofacial.

The major players in the industry are Thermo Fisher Scientific, Inc., Medtronic plc, Prospec-Tany Technogene Ltd., and Merck KGaA, among others.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-120-433-0800

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124